Wednesday, August 19, 2015

Zacks Downgrades Imprimis Pharmaceuticals to Sell (IMMY)

  1. Zacks Downgrades Imprimis Pharmaceuticals to Sell (IMMY)

    sleekmoney-10 hours ago
    Imprimis uses a commercial pathway using compounding pharmacies for the formulation and distribution of its proprietary drug therapies, which include ...

No comments: